Document is current

Any future updates will be listed below

Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells

Crossref DOI link: https://doi.org/10.1186/s13058-015-0534-y

Published Online: 2015-03-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark